RAAB G KIRK 4
4 · Transcept Pharmaceuticals Inc · Filed Feb 3, 2009
Insider Transaction Report
Form 4
RAAB G KIRK
Director
Transactions
- Award
Common Stock
2009-01-30+118,584→ 118,584 total - Award
Common Stock Option (right to buy)
2009-01-30+20,000→ 20,000 totalExercise: $4.50Exp: 2019-01-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Novacea, Inc. ("Novacea"), Pivot Acquisition, Inc. and Transcept Pharmaceuticals, Inc. ("Transcept"), dated as of August 29, 2008 (the "Merger Agreement"), each share of Transcept common stock converted into 0.141340 shares of Novacea common stock at the effective time of the merger. After completion of the merger, Novacea was renamed Transcept Pharmaceuticals, Inc. and began to trade under the stock symbol TSPT.
- [F2]The option vests in forty-eight equal monthly installments beginning on February 28, 2009.